Esteve Pharmaceuticals SRL

Esteve Pharmaceuticals reported revenue of 887,368 € for the 2025 financial year (annual accounts filed with the NBB on 16 Oct 2026).

By total assets for 2025, Esteve Pharmaceuticals ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0543.727.164 · VAT BE0543727164
1090 Jette
active in Wholesale of pharmaceutical and medical goods (NACE 46460)
operating since 02 Jan 2014 (≈ 12 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Esteve Pharmaceuticals shows with a free account.

See the score
Profile
SRL since 2014
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue887,368 €
Net result−130,435 €
Equity703,944 €
EBITDA−23,947 €
Total assets€2.91m
The line marks its sector median: 32.3% (146 companies).

Change 2022 → 2025: Revenue -86 % Equity -10 % Total assets -8 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Esteve Pharmaceuticals's annual accounts

20252024202320222021
Revenue887,368 €
Net result−130,435 €
Equity703,944 €
EBITDA−23,947 €
Total assets€2.91m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 16 Oct 2026
  • Year ended 31 Dec 2024filed on 01 Jul 2025
  • Year ended 31 Dec 2023filed on 25 Jun 2024
  • Year ended 31 Dec 2022filed on 05 Jun 2023
  • Year ended 31 Dec 2021filed on 31 Aug 2022

Esteve Pharmaceuticals's financial analysis

Management and control of Esteve Pharmaceuticals

2 active director(s) in the register.

Esteve Pharmaceuticals's shareholders and holdings →

Esteve Pharmaceuticals's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0543.727.164
VAT number
BE0543727164
Peppol
Registered · 0208:0543727164 · as of 10 Nov 2026
Legal form
SRL
Incorporated
02 Jan 2014
Registered office
1090 Jette
Latest accounts
2025 · filed on 16 Oct 2026
Activity
Wholesale of pharmaceutical and medical goods (NACE 46460)

Esteve Pharmaceuticals (SRL) has been based in Jette since 2014, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of 887,368 €, a net loss of 130,435 € and equity of 703,944 €. Its solvency stands at 24.2%, below the median of its sector (32.3%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Esteve Pharmaceuticals

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Esteve Pharmaceuticals

What is the revenue of Esteve Pharmaceuticals?

According to the 2025 annual accounts filed with the NBB, the revenue of Esteve Pharmaceuticals amounts to 887,368 €.

What is the VAT number of Esteve Pharmaceuticals?

In Belgium, the VAT number is the company number prefixed with BE: BE0543727164 for Esteve Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0543.727.164.

Where is the registered office of Esteve Pharmaceuticals?

According to the CBE register, the registered office of Esteve Pharmaceuticals is in 1090 Jette.

What is the equity of Esteve Pharmaceuticals?

At the close of the 2025 financial year, the equity of Esteve Pharmaceuticals amounts to 703,944 €, a solvency of 24.2% of total assets.

Who manages Esteve Pharmaceuticals?

The register lists 2 active mandates at Esteve Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Esteve Pharmaceuticals within its sector?

By total assets for 2025, Esteve Pharmaceuticals ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.

Idonis

The full file of Esteve Pharmaceuticals

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 17 Oct 2026

No credit card, no commitment.

What each plan unlocks →